Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
TL-925 for Allergic Eye
Recruiting0 awardsPhase 2
Andover, Massachusetts
This trial will involve 70 participants who will be randomly assigned to receive either TL-925 eye drops or a placebo. The study will assess the effectiveness of TL-925 in treating allergic conjunctiv
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.